# Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination

> **NCT05945524** · NA · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 100 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** Bone marrow sampling

## Key facts

- **NCT ID:** NCT05945524
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-28
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05945524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05945524, "Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05945524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*